XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - Stock Option Activity (Details) - USD ($)
9 Months Ended
May 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Number of Options        
Granted (in shares) 1,697,712      
Options to purchase Common Stock        
Weighted-average assumptions        
Risk-free interest rate   4.06% 3.62%  
Dividend yield (as a percent)   0.00% 0.00%  
Expected volatility (as a percent)   106.00% 109.00%  
Expected term   5 years 9 months 18 days 5 years 3 months 18 days  
Number of Options        
Balance outstanding at the beginning of the period (in shares)   6,650,954    
Granted (in shares)   1,899,096    
Exercised (in shares)   (133,614)    
Forfeited and expired (in shares)   (68,092)    
Balance outstanding at the end of the period (in shares)   8,348,344    
Exercisable at the end of the period (in shares)   4,431,853    
Vested and expected to vest (in shares)   8,132,900    
Weighted Average Exercise Price Per Share        
Balance outstanding at the beginning of the period (in USD per share)   $ 4.27    
Granted (in USD per share)   3.4    
Exercised (in USD per share)   2.69    
Forfeited and expired (in USD per share)   23.06    
Balance outstanding at the end of the period (in USD per share)   3.94    
Exercisable at the end of the period (in USD per share)   4.64    
Vested and expected to vest (in USD per share)   $ 3.97    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures        
Options outstanding, intrinsic value   $ 2,542,885   $ 23,926
Exercisable at the end of the period, intrinsic value   1,235,936    
Vested and expected to vest, intrinsic value   $ 2,451,731    
Inducement Grant Stock Options        
Number of Options        
Granted (in shares)   1,380,248